This report agreed by three European Commission committees in January 2009 forms part of the European Commission’s “risk assessment dialogues”, and concluded “that risk assessment of compounds that are both genotoxic and carcinogenic should be done on a case-case basis.” Note: Most substances in common workplace use have not been subject to any meaningful assessment of potential chronic health associations.

Risk assessment methodologies and approaches for genotoxic and carcinogenic substances, European Commission Health and Consumer Protection Directorate: Scientific Committee on Health and Environmental Risks (SCHER); Scientific Committee on Consumer Products (SCCP); and Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), adopted by all three committees January 2009.